ELTP
ELITE PHARMACEUTICALS INC /NV/
+0.01 (+3.42%)0.25USD20.0K成交股數267M市值5.0本益比(近四季)1.9股價營收比-19.5%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 3 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 32.4M-20% | 40.7M+184% | 31.6M+67% | 36.3M+93% | 40.2M+124% | 14.4M-8% | 18.9M+33% | 18.8M+109% | 17.9M | 15.5M | 14.2M | 9.0M |
| 營業成本 | 18.8M | 20.0M | 18.6M | 22.2M | 13.0M | 8.2M | 10.7M | 10.3M | 9.8M | 8.5M | 7.7M | 4.2M |
| 毛利 | 13.5M-50% | 20.8M+239% | 13.0M+58% | 14.1M+66% | 27.2M+235% | 6.1M-13% | 8.2M+27% | 8.5M+78% | 8.1M | 7.0M | 6.4M | 4.8M |
| 毛利率 | 41.7% | 51.0% | 41.0% | 38.7% | 67.7% | 42.6% | 43.4% | 45.1% | 45.2% | 45.3% | 45.5% | 52.9% |
| 研發費用 | 2.0M | 1.6M | 1.0M | 1.4M | 1.7M | 1.8M | 2.0M | 2.2M | 1.7M | 1.4M | 2.6M | 1.1M |
| 銷售管理費用 | 3.5M | 7.7M | 2.5M | 4.0M | 3.4M | 2.7M | 2.3M | 2.0M | 2.2M | 1.7M | 1.5M | 1.7M |
| 營業利益 | 7.5M-65% | 10.2M+828% | 9.0M+159% | 8.2M+113% | 21.7M+482% | 1.1M-69% | 3.5M+81% | 3.9M+141% | 3.7M | 3.5M | 1.9M | 1.6M |
| 營業利益率 | 23.3% | 25.0% | 28.5% | 22.6% | 54.0% | 7.6% | 18.5% | 20.6% | 20.8% | 22.7% | 13.6% | 17.8% |
| 稅後淨利 | 5.9M-200% | 18.5M-269% | 18.6M-268% | 13.7M+2125% | −5.9M-277% | −10.9M-1642% | −11.0M-174% | 616K-46% | 3.3M | 706K | 14.9M | 1.1M |
| 淨利率 | 18.3% | 45.3% | 58.9% | 37.7% | -14.6% | -75.8% | -58.5% | 3.3% | 18.5% | 4.5% | 105.5% | 12.7% |
| 稀釋 EPS | 0.01-200% | 0.02-300% | 0.01-200% | 0.01 | -0.01-200% | -0.01 | -0.01-200% | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 |
| 稀釋股數 | 1.13B | 1.14B | 1.14B | 1.14B | 1.07B | 1.07B | 1.07B | 1.08B | 1.02B | 1.02B | 1.02B | 1.01B |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 39.4M | 30.3M | 21.6M | 27.1M | 22.2M | 8.7M | 10.0M | 8.8M | 7.1M | 5.8M | 8.7M | 9.1M |
| 應收帳款 | 50.4M | 59.7M | 48.5M | 40.9M | 36.2M | 18.5M | 21.4M | 20.5M | 19.5M | 16.0M | 10.5M | 6.2M |
| 存貨 | 24.2M | 21.3M | 25.1M | 18.2M | 19.4M | 20.2M | 14.2M | 13.8M | 12.9M | 14.3M | 15.2M | 11.2M |
| 總資產 | 140M | 138M | 126M | 117M | 111M | 90.8M | 88.2M | 87.8M | 83.7M | 74.7M | 70.7M | 46.5M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 34.8M | 39.4M | 46.1M | 55.7M | 63.7M | 54.3M | 40.9M | 29.6M | 26.1M | 28.3M | 25.6M | 16.4M |
| 股東權益 | 105M | 98.9M | 80.3M | 61.6M | 47.7M | 36.4M | 47.3M | 58.3M | 57.6M | 46.4M | 45.1M | 30.1M |
| 負債比 | 24.9% | 28.5% | 36.5% | 47.5% | 57.2% | 59.8% | 46.4% | 33.7% | 31.2% | 37.9% | 36.2% | 35.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | 10.1M-32% | – | – | – | 14.8M | – | – | 3.1M-216% | – | – | – | −2.7M |
| 資本支出 | 809K | – | – | – | 218K | – | – | 779K | – | – | – | – |
| 自由現金流 | 9.3M-36% | – | – | – | 14.6M | – | – | 2.4M | – | – | – | – |
| 折舊攤銷 | 253K | 252K | 269K | 275K | 275K | 313K | 227K | 322K | 321K | 344K | 327K | 328K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | 28.6% | – | – | – | 36.2% | – | – | 12.6% | – | – | – | – |
營收拆解 2026 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2026 年度 · 297M
| Scheduled Products Manufacturing Fees | 141M | 47.7% | +89.2% |
|---|---|---|---|
| Indirect Sales To Wholesalers | 82.5M | 27.8% | +142.9% |
| Direct Sales To Wholesalers | 65.3M | 22.0% | +36.0% |
| Un Scheduled Products Manufacturing Fees | 6.3M | 2.1% | -12.2% |
| Unscheduled Products Licensing Fees | 594K | 0.2% | -67.1% |
| Scheduled Products Licensing Fees | 466K | 0.2% | +87.1% |
| Manufacturing 小計 | 148M | 49.8% | +80.3% |
| Manufacturing Fees 小計 | 148M | 49.8% | +80.3% |
| 授權 小計 | 1.1M | 0.4% | -48.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 149M | +77.1% | 44.9M | 30.1% | 0.03 | 22.8M |
| FY2025 | 84.0M | +48.4% | −4.3M | -5.1% | 0.00 | 5.8M |
| FY2024 | 56.6M | +65.8% | 20.1M | 35.5% | 0.02 | −4.0M |
| FY2023 | 34.2M | +5.9% | 3.6M | 10.4% | 0.00 | −2.4M |
| FY2022 | 32.3M | +27.1% | 8.9M | 27.6% | 0.01 | 6.0M |
| FY2021 | 25.4M | +41.0% | 5.1M | 20.0% | 0.00 | – |
| FY2020 | 18.0M | +137.8% | −2.2M | -12.5% | 0.00 | – |
| FY2019 | 7.6M | – | −9.3M | -122.6% | -0.01 | – |